Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06742554Phase 4Active, not recruiting
Phase 4, randomised trial of v1003 in postoperative pain (2 arms). Primary endpoints: Postoperative pain score at 72 hours and Duration of Effective Analgesia at 72 hours. Started Dec 2024; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06742554.